- Home
- IGC vs SDST Comparison
IGC vs SDST Comparison
Compare IGC & SDST Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | IGC | SDST |
|---|---|---|
| Founded | 2005 | 2022 |
| Country | United States | United States |
| Employees | N/A | 8 |
| Industry | Biotechnology: Pharmaceutical Preparations | Blank Checks |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.5M | 27.9M |
| IPO Year | 2005 | N/A |
Fundamental Metrics
Financial Performance| Metric | IGC | SDST |
|---|---|---|
| Price | $0.27 | $2.44 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 1 | 2 |
| Target Price | $5.00 | ★ $17.00 |
| AVG Volume (30 Days) | ★ 266.2K | 60.5K |
| Earning Date | 06-24-2026 | 03-17-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 59.09 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,271,000.00 | N/A |
| Revenue This Year | $3.54 | N/A |
| Revenue Next Year | $15.12 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.24 | $0.14 |
| 52 Week High | $0.50 | $7.67 |
Technical Indicators
Market Signals| Indicator | IGC | SDST |
|---|---|---|
| Relative Strength Index (RSI) | 44.70 | 28.90 |
| Support Level | N/A | $0.29 |
| Resistance Level | $0.32 | $3.00 |
| Average True Range (ATR) | 0.02 | 0.26 |
| MACD | -0.00 | -0.08 |
| Stochastic Oscillator | 12.18 | 11.93 |
Price Performance
Historical ComparisonAbout IGC IGC Pharma Inc.
IGC Pharma Inc develops cannabinoid-based formulations for treating diseases and conditions, including, but not limited to, Alzheimer's disease, period cramps, premenstrual syndrome, and chronic pain. The company has investigational drug assets targeting Alzheimer's disease, IGC-AD1, IGC-M3, IGC-1C, and TGR-63, which have demonstrated in Alzheimer's cell lines the potential to be effective in suppressing or ameliorating key hallmarks of Alzheimer's disease, such as plaques or tangles.
About SDST Stardust Power Inc.
Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).